Reports Hub

People in Birmingham and Solihull will benefit from improvements made to the NHS prostate cancer pathway by University Hospitals Birmingham NHS Foundation Trust (UHB), following Healthwatch Birmingham and Healthwatch Solihull’s joint report Experiences of the NHS prostate cancer pathway in Birmingham and Solihull in July 2023.

The report highlighted the importance of the service being responsive to the needs of users alongside patients’ concerns regarding the lack of information about treatment options, the slow pace of treatment and limited post-treatment support.

After changes made in response to the report, people seeking care/support should now experience:

• Improved access to appointments and diagnosis
• More holistic needs assessments being undertaken
• Improvement in the post-treatment support they receive
• Improved experience of care and support

Healthwatch Birmingham and Healthwatch Solihull will continue to liaise with UHB to ensure that improvements lead to a positive impact on patients and their outcomes.

Healthwatch Solihull followed up with Birmingham and Solihull ICB and University Hospitals Birmingham six months following our initial report to find out what improvements had been made.

You can read the report below.